在复发性/耐药性多发性髓瘤患者中,对全人类BCMA向的CAR T细胞疗法zevorcabtagene autoleucel进行II期研究

相关实验视频

Updated: Jan 16, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.7K

Wenming Chen1, Chengcheng Fu2, Baijun Fang3

  • 1Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China. 13910107759@163.com.

Experimental hematology & oncology
|October 1, 2025
PubMed
概括

泽沃卡巴丁基自杀细胞 (zevor-cel) 在复发性/耐药性多发性骨髓瘤患者中显示出92.2%的客观反应率. 这种CAR T细胞疗法显示出深度和持久的反应,具有可管理的安全性.

关键词:
这就是为什么BCMABCMABCMA.在CAR T细胞中,CT053 是一个人.化学抗原受体T细胞的T细胞.复发性/耐药性多发性骨髓瘤有针对性的免疫疗法.泽沃尔-塞尔 (Zevor-cel) 是一个古老的城市.泽沃卡巴塔基因自杀细胞

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K